Stoke Therapeutics Announces Publication of Data in the Journal Nature Communications That Support the Company’s Proprietary Approach to Addressing Severe Genetic Diseases by Precisely Upregulating Protein ExpressionBusiness Wire • 07/09/20
Stoke Therapeutics, Inc. (STOK) Shares March Higher, Can It Continue?Zacks Investment Research • 12/19/19